SJM Seeks Faster Biosimilar Approvals to Boost Access

SJM, an economic group, wants to make biosimilar medicines easier to get in India.

They are asking the government to speed up approvals and skip animal tests if lab results show the medicine is similar to the original.

They point out that other countries already do this and it helps keep costs down.

SJM believes this will make the medicines cheaper and more accessible, especially for people with serious illnesses and those in rural areas.

They also want clear rules for clinical trials to avoid confusion and ensure fairness.